
Low Dose Naltrexone (LDN) is derived from Naltrexone, a drug used to treat opioid addicts. In the 1980s, a doctor from New York, Dr. Bihari, discovered that at a low dose the drug has an interesting effect on the immune system. Taken between 9:00 p.m. and 3:00 a.m., LDN causes an increase in endorphin production, which helps strengthen and normalize the immune system.
Strengthening and normalizing the immune system has a couple benefits. Besides making it easier to fight off infection and disease, it also lessens the occurrence of chronic inflammation, which is linked to autoimmune disorders like Multiple Sclerosis. Today LDN has been found to benefit many conditions.
HOW I USE LDN
As a woman with Multiple Sclerosis (MS),I use LDN to help manage my MS. When I discovered that inflammation causes MS relapses, with relapses being the worsening of current or creation of new MS symptoms, I incorporated LDN into my life to do the following:
- Manage chronic inflammation.
- Fight/prevent infections, which are major sources of inflammation.
And managing inflammation helps manage my MS.
In 2010, I incorporated LDN into my daily routine and I’m so glad I did. It helped me manage my chronic inflammation and significantly lessen my MS symptoms, especially the fatigue I experienced. I’ve been taking it ever since.
In early 2024, I lost my LDN provider. I went a couple months without LDN and the resulting fatigue was crippling. Luckily, I found a new provider and started taking it again. The fatigue went away and I was able to function again.
After several months with my new provider, I was asked if I would be interested in trying a higher dose. I decided to try it and after a couple months started experiencing increased mental clarity and a slow, but steady, weight loss.
RESOURCES
I rely on the LDN Research Trust and LDN Science for information on LDN and the latest research. They also maintain lists of doctors who prescribe LDN.
CAUTION
Since LDN does not get along well with some medications and medical conditions, I’m careful to check for contraindications.
-Jen, aka. Power Chair Dorothy
REFERENCES
Bihari, B. (2013). Bernard Bihari, MD: Low-dose Naltrexone for Normalizing Immune System Function. Alternative Therapies, 19(2), 56-65.
Kulak-Bejda, A., Bejda, G., & Waszkiewicz, N. (2020). Safety and efficacy of naltrexone for weight loss in adult patients – a systematic review. Archives of medical science : AMS, 17(4), 940–953.
Ludwig, M. D., Turel, A. P., Zagon, I. S., & McLaughlin, P. J. (2016). Long-term Treatment with Low Dose Naltrexone Maintains Stable Health in Patients with Multiple Sclerosis. Multiple Sclerosis Journal – Experimental, Translational and Clinical, 2, 1-11. doi: 10.1177/2055217316672242.
Parkitny, L. & Younger, J. (2017). Reduced Pro-Inflammatory Cytokines after Eight Weeks of Low-Dose Naltrexone for Fibromyalgia. Biomedicines, 5(2). doi: 10.3390/biomedicines5020016.
Toljan, K., and Vrooman, B. (2018). Low-Dose Naltrexone (LDN)—Review of Therapeutic Utilization. Medical Sciences, 6(4), E82. doi: 10.3390/medsci6040082.
Younger, J., Parkitny, L., & McLain, D. (2014). The Use of Low-dose Naltrexone (LDN) as a Novel Anti-inflammatory Treatment for Chronic Pain. Clinical Rheumatology, 33(4), 451–459. doi: 10.1007/s10067-014-2517-2.
Not in Kansas Anymore (www.notinksanymore.com) is a site/blog authored and managed by Jen, aka. Power Chair Dorothy (pwrchr-dorothy). This site/blog is intended to provide educational and research information, and to share the author’s journey.
The author of this site/blog is not a medical physician and this site/blog does not provide medical advice. This site/blog contains information that should not be used in place of a visit, call, consultation or the advice of your physician or other qualified healthcare provider. If you choose to apply or implement any information posted at this site/blog, you do so at your own risk.
